Cell Point

What does Cell Point do?

Cell Point (India) Ltd is a micro-cap retail company incorporated in 2013, converted to a public limited company in 2022, with no recent sales or profit data reported. It has a market cap of Rs 35 Cr, a P/E ratio of 35.00, and a dividend yield of 1.07%.

Overview: <BR>Cell Point (India) Ltd operates in the retailing industry and is classified as a micro-cap company.<BR><BR>History: <BR>Cell Point (India) Ltd was incorporated on April 10, 2013, under the name 'Cell Point (India) Private Limited' and was later converted to a public limited company on November 25, 2022. There is no sales or profit data reported for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: Rs 35 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 35.00 <BR>Industry P/E: 30 <BR>Dividend Yield: 1.07% <BR>Debt-Equity: 0.51 <BR>Return on Equity: 0.51% <BR>Price-to-Book: 0.48 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

When is the next results date for Cell Point?

No Upcoming Board Meetings

Has Cell Point declared dividend?

Yes, Cell Point (India) Ltd has declared a 2% dividend, amounting to ₹0.20 per share, with an ex-date of September 19, 2024. However, the company has experienced significant price declines, resulting in negative total returns over various periods.

Cell Point (India) Ltd has declared a 2% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2%<BR>- Amount per share: ₹0.20<BR>- Ex-date: 19 Sep 2024<BR><BR>Dividend Yield: 1.07%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -34.26%, the dividend return was 0%, resulting in a total return of -34.26%.<BR><BR>For the 1-year period, the price return was -46.31%, the dividend return was 0.56%, leading to a total return of -45.75%.<BR><BR>Over the 2-year period, there was no price return or dividend return, resulting in a total return of 0.0%.<BR><BR>In the 3-year period, both the price return and dividend return were 0%, resulting in a total return of 0.0%.<BR><BR>For the 4-year period, there were no changes in price or dividends, leading to a total return of 0.0%.<BR><BR>In the 5-year period, there was again no price or dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, while Cell Point has declared a dividend, the total returns over various periods indicate significant losses in the short term, with no returns from dividends in most periods. The company appears to be struggling, as reflected in the negative price returns.

What is the technical trend for Cell Point?

As of May 12, 2025, Cell Point's trend is mildly bearish, influenced by daily moving averages and Bollinger Bands, despite a mildly bullish indication from the weekly MACD and KST.

As of 12 May 2025, the technical trend for Cell Point has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages reflect a mildly bearish trend. The Bollinger Bands are bearish on both weekly and monthly time frames, and the RSI shows no signal in both time frames. The KST and Dow Theory are mildly bullish on the weekly and monthly charts, providing some support to the overall outlook. Overall, the current stance is mildly bearish, driven primarily by the daily moving averages and Bollinger Bands.

Who are the peers of the Cell Point?

Cell Point's peers include Purv Flexi, Silgo Retail, Magson Retail, Fonebox Retail, Sattva Sukun, Kotia Enterprise, Ace Men, Radhagobind Comm, and MRP Agro. In terms of management risk, Cell Point has an average rating, with its 1-year return at -47.50%, better than Purv Flexi's -54.91% but worse than Silgo Retail's 63.48%.

Peers: The peers of Cell Point are Purv Flexi, Silgo Retail, Magson Retail, Fonebox Retail, Sattva Sukun, Kotia Enterprise, Ace Men, Radhagobind Comm, MRP Agro.<BR><BR>Quality Snapshot: Excellent management risk is observed at Fonebox Retail and MRP Agro, while Good management risk is found at Magson Retail. Average management risk is present at Cell Point, and Below Average management risk is noted at Purv Flexi, Silgo Retail, Sattva Sukun, Kotia Enterprise, Ace Men, and the rest. Growth is Excellent at Sattva Sukun, Good at Magson Retail and MRP Agro, Below Average at Cell Point, Purv Flexi, Silgo Retail, Kotia Enterprise, Ace Men, and the rest. Capital Structure is Good at Magson Retail, Sattva Sukun, and Ace Men, while Below Average is seen at Cell Point, Purv Flexi, Silgo Retail, Kotia Enterprise, and the rest.<BR><BR>Return Snapshot: Silgo Retail has the highest 1-year return at 63.48%, while Purv Flexi has the lowest at -54.91%. Cell Point's 1-year return of -47.50% is better than Purv Flexi's but worse than Silgo Retail's. Additionally, the six-month returns are negative for Purv Flexi, Fonebox Retail, and Cell Point.

Who are the top shareholders of the Cell Point?

The top shareholder of Cell Point is Mohan Prasad Panday, who holds 64.54% of the shares. Individual investors own 24.39%, with no pledged promoter holdings or investments from mutual funds or foreign institutional investors.

The top shareholders of Cell Point are primarily the promoters, with Mohan Prasad Panday holding the largest share at 64.54%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Individual investors collectively hold 24.39% of the shares.

How big is Cell Point?

As of 24th July, Cell Point (India) Ltd has a market capitalization of 35.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest 4 quarters.

As of 24th July, <BR><BR>Market Cap: Cell Point (India) Ltd has a market capitalization of 35.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest 4 quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds valued at 72.12 Cr and Total Assets amounting to 133.10 Cr.

How has been the historical performance of Cell Point?

Cell Point has shown consistent growth in net sales, reaching 324.71 Cr in March 2025, but profitability metrics have fluctuated, with operating profit declining from 19.34 Cr in March 2023 to 8.88 Cr in March 2025. Total assets increased to 137.69 Cr in March 2025, while cash flow improved to 0.00 Cr, indicating ongoing liquidity challenges.

Answer:<BR>The historical performance of Cell Point shows a steady increase in net sales over the years, reaching 324.71 Cr in March 2025, up from 321.23 Cr in March 2024, and significantly higher than 295.67 Cr in March 2023. The total operating income mirrored this trend, with a rise to 324.71 Cr in March 2025 from 321.23 Cr in the previous year. However, the operating profit (PBDIT) has seen fluctuations, peaking at 19.34 Cr in March 2023 before declining to 8.88 Cr in March 2025. Profit before tax also experienced a decline, with 2.81 Cr reported in March 2025 compared to 9.87 Cr in March 2023. Profit after tax followed a similar pattern, increasing to 2.26 Cr in March 2025 from 1.69 Cr in March 2024 but down from 6.73 Cr in March 2023. <BR><BR>In terms of assets and liabilities, total assets grew to 137.69 Cr in March 2025 from 133.10 Cr in March 2024, with total liabilities also increasing to 137.69 Cr from 133.10 Cr. The company's cash flow from operating activities was notably negative in March 2024 at -7.00 Cr, but improved to 0.00 Cr in March 2025. The net cash outflow for March 2025 was -5.00 Cr, a decline from a net inflow of 1.00 Cr in March 2024. Overall, while Cell Point has shown growth in sales and total assets, profitability metrics have fluctuated, indicating challenges in maintaining profit levels in recent periods. <BR><BR>Breakdown:<BR>Cell Point's net sales have consistently increased, reaching 324.71 Cr in March 2025, up from 321.23 Cr in March 2024, and significantly higher than previous years. The total operating income followed suit, reflecting the same growth trajectory. However, operating profit (PBDIT) peaked at 19.34 Cr in March 2023 and has since declined to 8.88 Cr in March 2025, indicating volatility in profitability. Profit before tax also decreased to 2.81 Cr in March 2025 from a higher 9.87 Cr in March 2023, while profit after tax showed a slight increase to 2.26 Cr in March 2025 from 1.69 Cr in the prior year, but was down from 6.73 Cr in March 2023. On the balance sheet, total assets rose to 137.69 Cr in March 2025, with total liabilities matching this figure, reflecting a stable financial position despite the challenges in profitability. Cash flow from operating activities improved to 0.00 Cr in March 2025 after a negative performance in the previous year, though the net cash outflow indicates ongoing liquidity challenges.

Is Cell Point overvalued or undervalued?

As of November 14, 2025, Cell Point is considered overvalued with a PE ratio of 98.49, significantly higher than its peers, and despite a recent one-week return of 8.33%, it has declined 27.1% year-to-date, indicating it is not a favorable investment at its current price.

As of 14 November 2025, the valuation grade for Cell Point has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios highlight this concern, with a PE ratio of 98.49, an EV to EBIT of 23.77, and an EV to EBITDA of 13.30, all suggesting that the stock is priced significantly higher than its earnings potential.<BR><BR>In comparison to its peers, Cell Point's valuation appears particularly high when contrasted with PTC India, which has a PE ratio of 7.52 and is rated as very attractive, and Optiemus Infra, rated as fair with a PE of 75.09. This stark difference in valuation metrics underscores the overvaluation of Cell Point. Additionally, while the stock has shown a recent one-week return of 8.33% compared to the Sensex's 1.64%, its year-to-date performance is concerning, with a decline of 27.1% against a 9.58% rise in the Sensex, further reinforcing the notion that Cell Point is not a favorable investment at its current price.

Why is Cell Point (India) Ltd falling/rising?

As of 17-Mar, Cell Point (India) Ltd's stock price is Rs 13.55, down 2.17%, and has significantly underperformed the Sensex over various periods, with a year-to-date decline of 17.88%. The stock is trading below all moving averages and is nearing its 52-week low, indicating a bearish trend and declining investor participation.

As of 17-Mar, Cell Point (India) Ltd's stock price is falling, currently at Rs 13.55, which reflects a decrease of Rs 0.3 or 2.17%. The stock has underperformed significantly over various time periods, with a decline of 10.86% over the past week and 10.26% over the past month, compared to the Sensex, which has fallen only 2.80% and 8.34%, respectively. Year-to-date, the stock is down 17.88%, while the Sensex has decreased by 9.75%. Over the past year, Cell Point's stock has dropped 20.53%, contrasting sharply with the Sensex's gain of 4.76%.<BR><BR>Additionally, the stock is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The stock is also close to its 52-week low, just 1.85% away from Rs 13.3. Investor participation appears to be declining, with a delivery volume of 4.8k on March 16, which is down 4.76% from the 5-day average. This combination of factors contributes to the downward pressure on the stock price of Cell Point (India) Ltd.

Why is Cell Point (India) Ltd falling/rising?

As of 18-Mar, Cell Point (India) Ltd's stock price is currently at Rs 13.90, reflecting a 2.58% increase today. Despite this rise, the stock has a year-to-date decline of 15.76% and is trading below its moving averages, indicating a longer-term downtrend.

As of 18-Mar, Cell Point (India) Ltd's stock price is rising, currently at Rs 13.90, which reflects an increase of Rs 0.35 or 2.58%. This rise is notable as the stock has outperformed its sector by 1.09% today. Despite this positive movement, the stock has shown a decline over longer periods, with a year-to-date decrease of 15.76% and a one-year decline of 18.95%. <BR><BR>Additionally, the stock is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a general downtrend in its price over time. However, there has been a rise in investor participation, with a delivery volume of 4.8k on March 17, which is up by 5.26% compared to the 5-day average. This increase in trading activity may contribute to the current upward movement in the stock price. <BR><BR>Overall, while the stock is experiencing a rise today, it is important to consider its recent performance trends and the broader market context.

Why is Cell Point (India) Ltd falling/rising?

As of 19-Mar, Cell Point (India) Ltd's stock price is at 14.00, showing a slight increase today but a negative trend overall, with declines of 3.11% over the past week and 15.15% year-to-date. Despite outperforming its sector today, the stock remains below its moving averages, indicating ongoing challenges.

As of 19-Mar, Cell Point (India) Ltd's stock price is currently at 14.00, reflecting a change of 0.1 (0.72%) increase. Despite this slight rise today, the stock has shown a negative performance over various periods. Over the past week, the stock has decreased by 3.11%, and it has fallen by 7.89% over the last month. Year-to-date, the stock is down 15.15%, and it has experienced a significant decline of 18.84% over the past year, contrasting with a slight increase in the Sensex of 0.41% during the same period.<BR><BR>Today's performance indicates that Cell Point has outperformed its sector by 4.33%, which may contribute to the current rise in price. Additionally, there has been a notable increase in investor participation, with a delivery volume of 27.6k on March 18, representing a 447.62% rise compared to the 5-day average. However, the stock is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a general downward trend.<BR><BR>In summary, while there is a minor increase in the stock price today, the overall trend remains negative, with significant declines over the past weeks and months, suggesting that the stock is still facing challenges despite today's performance metrics.

Why is Cell Point (India) Ltd falling/rising?

As of 20-Mar, Cell Point (India) Ltd's stock price is rising to 14.30, up 2.14%, and has outperformed its sector today. However, it has a year-to-date decline of 13.33% and faces longer-term challenges despite short-term positive trends.

As of 20-Mar, Cell Point (India) Ltd's stock price is rising, currently at 14.30, reflecting an increase of 0.3 or 2.14%. This upward movement is notable as the stock has outperformed its sector by 0.59% today. Additionally, over the past week, the stock has shown a positive return of 3.25%, contrasting with a slight decline of 0.16% in the benchmark Sensex. <BR><BR>However, it is important to note that despite today's rise, the stock has experienced a decline over longer periods, including a year-to-date drop of 13.33% and a one-year decrease of 17.82%. The stock's current price is higher than its 5-day moving averages, indicating a short-term positive trend, although it remains below the longer-term moving averages of 20, 50, 100, and 200 days. <BR><BR>Investor participation appears to be falling, as evidenced by a significant drop in delivery volume, which decreased by 61.54% compared to the 5-day average. Despite this decline in participation, the stock remains liquid enough for trading. Overall, while the stock is currently rising, the broader trend shows significant challenges over the longer term.

Why is Cell Point (India) Ltd falling/rising?

As of 23-Mar, Cell Point (India) Ltd's stock price is Rs 13.60, down 4.9%, reflecting a broader bearish trend with declines over various periods and trading below moving averages. The stock is nearing its 52-week low, and investor participation is decreasing significantly.

As of 23-Mar, Cell Point (India) Ltd's stock price is falling, currently at Rs 13.60, which reflects a decrease of Rs 0.7 or 4.9%. This decline is consistent with the stock's performance over various periods, showing a 1-week drop of 1.81%, a 1-month decrease of 11.40%, and a year-to-date decline of 17.58%. Over the past year, the stock has fallen by 23.16%, while the benchmark Sensex has only decreased by 3.59% in the same timeframe.<BR><BR>Additionally, the stock is trading below its moving averages across multiple timeframes, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The stock is also close to its 52-week low, being just 2.21% away from Rs 13.3. Investor participation appears to be declining, with a significant drop in delivery volume of 35.9% compared to the 5-day average. These factors collectively contribute to the downward pressure on the stock price of Cell Point (India) Ltd.

Why is Cell Point (India) Ltd falling/rising?

As of 24-Mar, Cell Point (India) Ltd's stock price is rising to 14.00, up by 2.94%. This increase is driven by strong sector performance, increased investor participation, and short-term momentum, although it remains below longer-term moving averages.

As of 24-Mar, Cell Point (India) Ltd's stock price is rising, currently at 14.00, reflecting a change of 0.4 (2.94%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 2.05% today, indicating a stronger performance relative to its peers. Additionally, there has been a notable rise in investor participation, with a delivery volume of 9.6k on 23 March, which is up by 2.56% compared to the 5-day average delivery volume. <BR><BR>Moreover, while the stock is currently higher than its 5-day moving averages, it remains lower than the longer-term moving averages (20-day, 50-day, 100-day, and 200-day), suggesting that while there is short-term momentum, it may still be in a recovery phase relative to longer trends. Overall, these factors contribute to the stock's upward movement on this particular day.

Why is Cell Point (India) Ltd falling/rising?

As of 25-Mar, Cell Point (India) Ltd's stock price is slightly rising at 14.10, despite a year-to-date drop of -14.55% and a significant decline in investor participation. This suggests uncertainty about the stock's future performance.

As of 25-Mar, Cell Point (India) Ltd's stock price is rising slightly, currently at 14.10, reflecting a change of 0.1 (0.71%) upward. This increase comes despite the stock's overall underperformance in the sector today, where it has underperformed by -1.79%. Over the past week, the stock has shown a positive return of +1.44%, contrasting with the Sensex, which has declined by -1.98%. <BR><BR>However, the stock has been experiencing a decline over longer periods, with a year-to-date drop of -14.55% and a one-year decline of -17.54%. Additionally, investor participation has fallen significantly, with a delivery volume of 2.4k on 24 March, which is down by -76.74% compared to the 5-day average. This decline in participation could indicate a lack of confidence among investors, despite the recent minor uptick in price. <BR><BR>Overall, while there is a slight rise in the current stock price, the broader context of declining performance over longer periods and reduced investor activity suggests that the stock's future trajectory may remain uncertain.

Which are the latest news on Cell Point?